Shibo Yu

654 total citations · 1 hit paper
26 papers, 367 citations indexed

About

Shibo Yu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Shibo Yu has authored 26 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Shibo Yu's work include Ferroptosis and cancer prognosis (8 papers), Epigenetics and DNA Methylation (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Shibo Yu is often cited by papers focused on Ferroptosis and cancer prognosis (8 papers), Epigenetics and DNA Methylation (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Shibo Yu collaborates with scholars based in China, Netherlands and United States. Shibo Yu's co-authors include Lizhe Zhu, Yufeng Shi, Jianjun He, Yue Liu, Xi Chen, Leilei Wu, Yi Wang, Jin Zhang, Xiaoyun Shi and Siyuan Jiang and has published in prestigious journals such as Journal of Biological Chemistry, Frontiers in Immunology and Cell Reports.

In The Last Decade

Shibo Yu

23 papers receiving 361 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An Overview: The Diversified Role of Mitochondria in Cancer Metabolism

2023 137 citations Yue Liu, Xiaoyun Shi et al. International Journal of Biological Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shibo Yu China	10	175	124	112	92	42	26	367
Xiaoli Liao China	13	238 1.4×	120 1.0×	74 0.7×	110 1.2×	50 1.2×	29	426
Jianzhuang Ren China	12	180 1.0×	102 0.8×	88 0.8×	82 0.9×	46 1.1×	26	401
Iwao Shimomura Japan	9	212 1.2×	101 0.8×	116 1.0×	123 1.3×	62 1.5×	13	415
Ailing Zhong China	13	192 1.1×	104 0.8×	59 0.5×	124 1.3×	23 0.5×	29	355
Yunhua Xu China	13	365 2.1×	193 1.6×	136 1.2×	107 1.2×	52 1.2×	25	528
Zirui Zhao China	9	241 1.4×	195 1.6×	122 1.1×	93 1.0×	84 2.0×	18	429
Mehrdokht Sadrkhanloo Iran	8	245 1.4×	180 1.5×	57 0.5×	88 1.0×	46 1.1×	10	381
Lin Zhong China	9	304 1.7×	220 1.8×	221 2.0×	111 1.2×	43 1.0×	21	523
Yolla Haibe Lebanon	8	196 1.1×	106 0.9×	51 0.5×	155 1.7×	49 1.2×	15	404
Anli Jin China	10	211 1.2×	115 0.9×	54 0.5×	90 1.0×	81 1.9×	15	387

Countries citing papers authored by Shibo Yu

Since Specialization

Citations

This map shows the geographic impact of Shibo Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shibo Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shibo Yu more than expected).

Fields of papers citing papers by Shibo Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shibo Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shibo Yu. The network helps show where Shibo Yu may publish in the future.

Co-authorship network of co-authors of Shibo Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Shibo Yu. A scholar is included among the top collaborators of Shibo Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shibo Yu. Shibo Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Everts, Marieke, Arkajyoti Bhattacharya, Shibo Yu, et al.. (2025). MYC controls STING levels to downregulate inflammatory signaling in breast cancer cells upon DNA damage. Journal of Biological Chemistry. 301(6). 108560–108560.

Yu, Shibo, Mengting Chen, Arkajyoti Bhattacharya, et al.. (2025). Cyclin E1 overexpression triggers interferon signaling and is associated with antitumor immunity in breast cancer. Journal for ImmunoTherapy of Cancer. 13(3). e009239–e009239.

Zhou, Yudong, Shibo Yu, Lizhe Zhu, et al.. (2025). Molecular biomarkers for the prognosis of breast cancer: role of amino acid metabolism genes. Journal of Physiology and Biochemistry. 81(2). 441–457.

Chen, Mengting, Nathalie van den Tempel, Arkajyoti Bhattacharya, et al.. (2024). Functional ex vivoDNA fibre assay to measure replication dynamics in breast cancer tissue. The Journal of Pathology. 264(1). 90–100. 1 indexed citations

Kok, Yannick P., Shibo Yu, Bert van de Kooij, et al.. (2024). RAD52-dependent mitotic DNA synthesis is required for genome stability in Cyclin E1-overexpressing cells. Cell Reports. 43(4). 114116–114116. 5 indexed citations

Zwager, Mieke C., Shibo Yu, Henk J. Buikema, et al.. (2024). Advancing Ki67 hotspot detection in breast cancer: a comparative analysis of automated digital image analysis algorithms. Histopathology. 86(2). 204–213. 1 indexed citations

Chen, Mengting, Shibo Yu, Tineke van der Sluis, et al.. (2024). cGAS-STING pathway expression correlates with genomic instability and immune cell infiltration in breast cancer. npj Breast Cancer. 10(1). 1–1. 25 indexed citations

Liu, Yue, Fei Wang, Shibo Yu, et al.. (2023). Deciphering the role of QPCTL in glioma progression and cancer immunotherapy. Frontiers in Immunology. 14. 1166377–1166377. 16 indexed citations

Liu, Yue, Xiaoyun Shi, Xi Chen, et al.. (2023). An Overview: The Diversified Role of Mitochondria in Cancer Metabolism. International Journal of Biological Sciences. 19(3). 897–915. 137 indexed citations breakdown →

10.

Kok, Yannick P., Shibo Yu, Jana Dobrovolná, et al.. (2023). PPM1D activity promotes the replication stress caused by cyclin E1 overexpression. Molecular Oncology. 18(1). 6–20. 2 indexed citations

11.

Zhu, Lizhe, Qi Tian, Siyuan Jiang, et al.. (2021). A Novel Ferroptosis-Related Gene Signature for Overall Survival Prediction in Patients With Breast Cancer. Frontiers in Cell and Developmental Biology. 9. 670184–670184. 25 indexed citations

12.

Wang, Shuang, Heping Li, Yu Ren, et al.. (2021). Studying the pathological and biochemical features in breast cancer progression by confocal Raman microspectral imaging of excised tissue samples. Journal of Photochemistry and Photobiology B Biology. 222. 112280–112280. 6 indexed citations

13.

Yu, Shibo, et al.. (2021). A nomogram based on CENPP expression for survival prediction in breast cancer. Gland Surgery. 10(6). 1874–1888. 2 indexed citations

14.

Xie, Peiling, Rui An, Shibo Yu, Jianjun He, & Huimin Zhang. (2021). A novel immune subtype classification of ER-positive, PR-negative and HER2-negative breast cancer based on the genomic and transcriptomic landscape. Journal of Translational Medicine. 19(1). 398–398. 12 indexed citations

15.

Yu, Shibo, Xiaowen Wang, Lizhe Zhu, et al.. (2021). A systematic analysis of a potential metabolism-related prognostic signature for breast cancer patients. Annals of Translational Medicine. 9(4). 330–330. 7 indexed citations

16.

Zhu, Lizhe, Siyuan Jiang, Shibo Yu, et al.. (2020). Increased SIX‐1 expression promotes breast cancer metastasis by regulating lncATB‐miR‐200s‐ZEB1 axis. Journal of Cellular and Molecular Medicine. 24(9). 5290–5303. 6 indexed citations

17.

Zhou, Can, Shibo Yu, Xiaoqin Liao, et al.. (2020). Major Postoperative Complications in Esophageal Cancer After Minimally Invasive Esophagectomy Compared With Open Esophagectomy: An Updated Meta-analysis. Journal of Surgical Research. 257. 554–571. 11 indexed citations

18.

Zhu, Lizhe, Wei Wu, Siyuan Jiang, et al.. (2020). Pan-Cancer Analysis of the Mitophagy-Related Protein PINK1 as a Biomarker for the Immunological and Prognostic Role. Frontiers in Oncology. 10. 569887–569887. 24 indexed citations

19.

Yu, Shibo, Lizhe Zhu, Ke Wang, et al.. (2019). Green tea consumption and risk of breast cancer. Medicine. 98(27). e16147–e16147. 26 indexed citations

20.

Yu, Shibo, et al.. (2016). Study on the Protective Effect of Uygur Medicine Nigellae Semenon on Acute Alcoholic Liver Injury Mice and its Inhibition on NF-B Signaling Pathway. 11(9). 1834. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact